Technical Analysis for ATRS - Antares Pharma, Inc.

Grade Last Price % Change Price Change
grade D 3.12 6.85% 0.20
ATRS closed up 6.85 percent on Friday, June 5, 2020, on 1.32 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical ATRS trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Weak + Overbought Other 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Shooting Star Candlestick Bearish 6.85%
Up 3 Days in a Row Strength 6.85%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide. The company's products include Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle; twin-jector EZ II needle free injectors; Medi-Jet auto injectors; Elestrin, an estrogen replacement gel for the treatment of hot flashes; and Gelnique 3%, an oxybutynin gel product for the treatment of overactive bladder. The company is also developing OTREXUP, a product for the delivery of methotrexate using Medi-Jet technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis, and psoriasis; and VIBEX QS T, an auto injector for the treatment of testosterone deficiency or replacement therapy. In addition, it is developing Vibex auto injectors; disposable pen injectors; and Nestragel, a contraceptive gel. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; BioSante Pharmaceuticals, Inc.; Meda Pharmaceuticals; Population Council; and Pfizer Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.
Biotechnology Health Pharmaceutical Pharmacology Medical Equipment Rheumatoid Arthritis Psoriasis Overactive Bladder Testosterone Deficiency Teva Pharmaceutical Industries

Is ATRS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.13
52 Week Low 1.6
Average Volume 1,385,567
200-Day Moving Average 3.48
50-Day Moving Average 2.72
20-Day Moving Average 2.81
10-Day Moving Average 2.89
Average True Range 0.20
ADX 12.27
+DI 30.52
-DI 19.06
Chandelier Exit (Long, 3 ATRs ) 2.58
Chandelier Exit (Short, 3 ATRs ) 3.00
Upper Bollinger Band 3.09
Lower Bollinger Band 2.53
Percent B (%b) 1.05
BandWidth 19.95
MACD Line 0.05
MACD Signal Line 0.02
MACD Histogram 0.0249
Fundamentals Value
Market Cap 487.99 Million
Num Shares 156 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -26.00
Price-to-Sales 5.48
Price-to-Book 7.21
PEG Ratio -0.24
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.49
Resistance 3 (R3) 3.47 3.33 3.43
Resistance 2 (R2) 3.33 3.24 3.34 3.41
Resistance 1 (R1) 3.23 3.18 3.28 3.24 3.39
Pivot Point 3.09 3.09 3.12 3.10 3.09
Support 1 (S1) 2.98 2.99 3.04 3.00 2.85
Support 2 (S2) 2.84 2.94 2.85 2.83
Support 3 (S3) 2.74 2.84 2.81
Support 4 (S4) 2.75